[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Alliance A151216 - Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

What is the purpose of the study? (in Layman's terms, please describe the study)

This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

Upstate Institutional Review Board (IRB) Number:

652783

Study/Protocol ID:

A151216

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Stephen L Graziano, MD

What is involved if I participate?

  • How long is the study?
    5 years
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No
  • What tests and procedures are involved?
    N/A

Where will the study take place?

Upstate Cancer Center-All procedures

Other Information:

N/A

ClinicalTrials.Gov ID:

NCT02194738

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Marissa Hartley
Phone: 315-464-8232
Email: hartlmar@upstate.edu

Return to Previous Page || Search Again

Top